As of 2025-07-07, the Relative Valuation of DongKoo Bio & Pharma Co Ltd (006620.KQ) is 129.82 KRW. This relative valuation is based on P/E multiples. With the latest stock price at 5,200.00 KRW, the upside of DongKoo Bio & Pharma Co Ltd based on Relative Valuation is -97.5%.
The range of the Relative Valuation is (922.62) - 1,834.42 KRW.
| Range | Selected | |
| Trailing P/E multiples | 8.6x - 15.5x | 11.5x |
| Forward P/E multiples | 12.9x - 18.2x | 14.8x |
| Fair Price | (922.62) - 1,834.42 | 129.82 |
| Upside | -117.7% - -64.7% | -97.5% |
| Date | P/E |
| 2025-07-03 | -48.75 |
| 2025-07-02 | -47.45 |
| 2025-07-01 | -47.35 |
| 2025-06-30 | -47.54 |
| 2025-06-27 | -48.10 |
| 2025-06-26 | -47.91 |
| 2025-06-25 | -48.94 |
| 2025-06-24 | -49.87 |
| 2025-06-23 | -49.40 |
| 2025-06-20 | -51.08 |
| 2025-06-19 | -51.27 |
| 2025-06-18 | -51.27 |
| 2025-06-17 | -51.27 |
| 2025-06-16 | -52.01 |
| 2025-06-13 | -51.55 |
| 2025-06-12 | -53.13 |
| 2025-06-11 | -53.50 |
| 2025-06-10 | -53.78 |
| 2025-06-09 | -54.81 |
| 2025-06-05 | -54.25 |
| 2025-06-04 | -54.34 |
| 2025-06-02 | -54.34 |
| 2025-05-30 | -53.41 |
| 2025-05-29 | -52.20 |
| 2025-05-28 | -51.64 |
| 2025-05-27 | -52.20 |
| 2025-05-26 | -53.50 |
| 2025-05-23 | -52.95 |
| 2025-05-22 | -53.60 |
| 2025-05-21 | -52.95 |
| 2025-05-20 | -53.13 |
| 2025-05-19 | -53.13 |
| 2025-05-16 | -54.62 |
| 2025-05-15 | -55.83 |
| 2025-05-14 | -54.06 |
| 2025-05-13 | -52.20 |
| 2025-05-12 | -50.43 |
| 2025-05-09 | -50.61 |
| 2025-05-08 | -50.71 |
| 2025-05-07 | -49.68 |
| 2025-05-02 | -49.87 |
| 2025-04-30 | -50.43 |
| 2025-04-29 | -51.27 |
| 2025-04-28 | -51.08 |
| 2025-04-25 | -52.57 |
| 2025-04-24 | -51.64 |
| 2025-04-23 | -52.01 |
| 2025-04-22 | -51.73 |
| 2025-04-21 | -52.85 |
| 2025-04-18 | -50.80 |